Log in or Sign up for Free to view tailored content for your specialty!
Sjögren’s Syndrome News
New ACR SSc-ILD guidelines warn against glucocorticoids as first-line therapy
The American College of Rheumatology “strongly recommends” against the use of glucocorticoids as a first-line therapy for interstitial lung disease in patients with systemic sclerosis-associated ILD, according to newly released guidelines.
Rheumatologists must be ‘more proactive’ in response to patients losing abortion access
Following last year’s U.S. Supreme Court’s decision overturning federal abortion protections, rheumatologists must change their practice with regard managing patients’ reproductive health, said presenter at the 2023 AWIR annual conference.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Latest Healio Rheumatology covers pediatric workforce shortage
Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, offered a breakdown of the June issue, which is led by a cover story on pediatric rheumatology workforce shortage concerns.
Pregnancies in patients with Sjögren’s syndrome have ‘very good prognoses’
Pregnancies among patients with Sjögren’s syndrome demonstrate “very good prognoses” for both the parent and fetus, and do not reflect an increased risk for adverse outcomes, according to data published in The Lancet Rheumatology.
Female patients with Sjögren’s syndrome more like to exhibit eye symptoms than males
There are several differences in the symptoms reported among male and female patients with primary Sjögren’s syndrome, according to data published in the Journal of Clinical Rheumatology.
EULAR launches first patient-reported survey on rheumatic, musculoskeletal disease impacts
EULAR has initiated a survey that will collect data directly from patients on the impact and outcomes of rheumatic and musculoskeletal diseases, according to a statement released during the EULAR 2023 Congress.
‘It takes a village’ to manage cardiovascular disease in patients with IMIDs
Properly managing cardiovascular disease in patients with immune-mediated inflammatory diseases requires following guidelines and inter-specialty collaboration, according to a speaker at the Biologic Therapies Summit.
New Sjӧgren’s syndrome therapies may target BAFF receptors, CD40
DESTIN, Fla. — Multiple potentially new therapies promise to improve the management of patients with Sjӧgren’s syndrome, according to a speaker at the 2023 Congress of Clinical Rheumatology meeting.
‘Pathogenic insights’ may help stratify Sjögren’s patients and inform treatment decisions
DESTIN, Fla. — Stratifying Sjögren’s disease patients by symptoms or biologic parameters may help rheumatologists hit therapeutic targets, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.
Hunting for the ‘elusive’ Sjögren’s diagnosis: How multiple specialties can improve delays
In rheumatology, there is no shortage of conditions that are difficult to diagnose, with diseases like fibromyalgia and systemic lupus erythematosus sometimes taking years before being officially identified — leading to adverse outcomes.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read